Vivo Bio Tech Board of Directors

Get the latest insights into the leadership at Vivo Bio Tech. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
AV KiranCompany Secretary & Compliance Officer
M Kalyan RamWhole Time Director
Alangudi SankaranarayananWhole Time Director
Shyam Sunder TipparajuNon Executive Independent Director
Priya Rajender GodaNon Executive Independent Director
Satyanarayana VedulaNon Independent & Non Executive Director
Sri Kalyan KompellaWhole Time Director & Chief Financial Officer

Vivo Bio Tech Share price

VIVOBIOT

28.49

0.00 (0.00%)
Last updated on 23 Apr, 2026 | 07:50 IST
Today's High

00

Today's Low

00

52 Week Low

20.35

52 Week High

43.35

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Vivo Bio Tech FAQs

The board at Vivo Bio Tech consists of experienced professionals, including AV Kiran, M Kalyan Ram, and others, overseeing the company’s strategic and corporate governance.

Directors at Vivo Bio Tech are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, AV Kiran is the current chairman at Vivo Bio Tech.

Executive directors at Vivo Bio Tech are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Vivo Bio Tech adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Vivo Bio Tech, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost